Literature DB >> 19787286

Significance of mucin expression in pancreatobiliary neoplasms.

Suguru Yonezawa1, Michiyo Higashi, Norishige Yamada, Seiya Yokoyama, Masamichi Goto.   

Abstract

Mucins are high molecular weight glycoproteins that play important roles in carcinogenesis and tumor invasion. We have described, for the first time, that pancreatic ductal adenocarcinomas (PDACs) with an aggressive behavior and a poor outcome expressed MUC1 (pan-epithelial membrane-associated mucin) but did not express MUC2 (intestinal-type secreted mucin), whereas intraductal papillary mucinous neoplasms (IPMNs) with indolent behavior and a favorable outcome did not express MUC1 but did express MUC2. These expression profiles of MUC1 and MUC2 related to the prognoses of the patients were also observed in biliary neoplasms such as intrahepatic cholangiocarcinoma (ICC)-mass-forming type (MF), mucin-producing bile duct tumor (MPBT), and extrahepatic bile duct carcinoma (EHBDC). We also found recently that high expression of MUC4 (tracheobronchial membrane-associated mucin) in PDACs, ICCs-MF, and EHBDCs was a new independent poor prognostic factor, although MUC4 was not expressed in normal pancreatobiliary tissue. High de novo expression of MUC5AC (gastric-type secreted mucin) was observed in many types of pancreatobiliary neoplasms, including all grades of pancreatic intraepithelial neoplasia (PanIN) and biliary intraepithelial neoplasia (BilIN), and all types of IPMNs and MPBTs, as well as PDACs and ICCs-MF, although MUC5AC was not expressed in normal pancreatobiliary tissue. The combined status of MUC1, MUC2, MUC4, and MUC5AC expression may be useful for the early detection of pancreatobiliary neoplasms and evaluation of their malignancy. In regard to the mechanism of mucin expression, we have recently reported that MUC1, MUC2, MUC4, and MUC5AC gene expression is regulated by epigenetics (DNA methylation and histone H3 lysine 9 modification) in cancer cell lines, including PDAC cells. Translational research of mucin gene expression mechanisms, including epigenetics, in pancreatobiliary neoplasms may give us new tools for the early and accurate detection of these neoplasms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19787286     DOI: 10.1007/s00534-009-0174-7

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  40 in total

1.  DNA methylation and histone H3-K9 modifications contribute to MUC17 expression.

Authors:  Sho Kitamoto; Norishige Yamada; Seiya Yokoyama; Izumi Houjou; Michiyo Higashi; Masamichi Goto; Surinder K Batra; Suguru Yonezawa
Journal:  Glycobiology       Date:  2010-10-06       Impact factor: 4.313

2.  Mucin expression in endoscopic ultrasound-guided fine-needle aspiration specimens is a useful prognostic factor in pancreatic ductal adenocarcinoma.

Authors:  Michiyo Higashi; Seiya Yokoyama; Takafumi Yamamoto; Yuko Goto; Ikumi Kitazono; Tsubasa Hiraki; Hiroki Taguchi; Shinichi Hashimoto; Yoshihiko Fukukura; Chihaya Koriyama; Yuko Mataki; Kosei Maemura; Hiroyuki Shinchi; Maneesh Jain; Surinder K Batra; Suguru Yonezawa
Journal:  Pancreas       Date:  2015-07       Impact factor: 3.327

Review 3.  Novel Biomarkers for Pancreatic Cysts.

Authors:  Harkirat Singh; Kevin McGrath; Aatur D Singhi
Journal:  Dig Dis Sci       Date:  2017-02-14       Impact factor: 3.199

4.  Fucosylation is associated with the malignant transformation of intraductal papillary mucinous neoplasms: a lectin microarray-based study.

Authors:  Kiminori Watanabe; Masayuki Ohta; Kazuhiro Yada; Yoko Komori; Yukio Iwashita; Kenji Kashima; Masafumi Inomata
Journal:  Surg Today       Date:  2016-01-11       Impact factor: 2.549

5.  Increased B7H4 tissue expression correlates with high CA19.9 serum levels and a worse prognosis of pancreatic adenocarcinoma.

Authors:  Anastasia Tsiaousidou; A K Tsaroucha; M Lambropoulou; M Pitiakoudis; A Polychronidis; E Chatzitheoklitos; K Romanidis; C Simopoulos
Journal:  Clin Exp Med       Date:  2015-04-30       Impact factor: 3.984

Review 6.  Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Víctor M Castellano-Megías; Carolina Ibarrola-de Andrés; Guadalupe López-Alonso; Francisco Colina-Ruizdelgado
Journal:  World J Gastrointest Oncol       Date:  2014-09-15

7.  Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma.

Authors:  Yoshiaki Kamikawa; Yuji Kanmura; Tomofumi Hamada; Norishige Yamada; Muzafar A Macha; Surinder K Batra; Michiyo Higashi; Suguru Yonezawa; Kazumasa Sugihara
Journal:  Int J Clin Oncol       Date:  2014-06-10       Impact factor: 3.402

8.  Usefulness of KL-6 in the subtyping of intraductal papillary mucinous neoplasia of the pancreas, including carcinoma, dysplasia, and hyperplasia.

Authors:  Yuji Ohtsuki; Ryohei Watanabe; Masashi Kimura; Katsuyoshi Nomura; Tomoharu Maeda; Katsumi Kito; Miyuki Takeji; Gang-Hong Lee; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2014-06-08       Impact factor: 2.309

9.  Tumor-infiltrating neutrophils in pancreatic neoplasia.

Authors:  Michelle D Reid; Olca Basturk; Duangpen Thirabanjasak; Ralpha H Hruban; David S Klimstra; Pelin Bagci; Deniz Altinel; Volkan Adsay
Journal:  Mod Pathol       Date:  2011-08-05       Impact factor: 7.842

Review 10.  Mucins in pancreatic cancer and its microenvironment.

Authors:  Sukhwinder Kaur; Sushil Kumar; Navneet Momi; Aaron R Sasson; Surinder K Batra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-16       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.